Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial

Double Blind ◽

Double Blind Placebo ◽

Motilin Receptor ◽

Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.12640 ◽

2014 ◽

Vol 39 (6) ◽

pp. 595-602 ◽

Cited By ~ 40

Author(s):

E. Thomas ◽

A. Wade ◽

G. Crawford ◽

B. Jenner ◽

N. Levinson ◽

...

Keyword(s):

Clinical Trial ◽

Pilot Study ◽

Reflux Disease ◽

Randomised Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Acid Pocket ◽

Nutrition Adequacy Therapeutic Enhancement in the Critically Ill: A Randomized Double-Blind, Placebo-Controlled Trial of the Motilin Receptor Agonist Camicinal (GSK962040): The NUTRIATE Study

Journal of Parenteral and Enteral Nutrition ◽

10.1002/jpen.1038 ◽

2017 ◽

Vol 42 (5) ◽

pp. 949-959 ◽

Cited By ~ 9

Author(s):

Adam M. Deane ◽

Francois Lamontagne ◽

George E. Dukes ◽

David Neil ◽

Lakshmi Vasist ◽

...

Keyword(s):

Critically Ill ◽

Receptor Agonist ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Motilin Receptor

Effects of domperidone in patients with chronic unexplained upper gastrointestinal symptoms: A double-blind, placebo-controlled study

Digestive Diseases and Sciences ◽

10.1007/bf01535938 ◽

1988 ◽

Vol 33 (12) ◽

pp. 1505-1511 ◽

Cited By ~ 70

Author(s):

Richard H. Davis ◽

Mary H. Clench ◽

John R. Mathias

Keyword(s):

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled

Diabetes Obesity and Metabolism ◽

10.1111/dom.12382 ◽

2014 ◽

Vol 16 (12) ◽

pp. 1257-1264 ◽

Cited By ~ 62

Author(s):

J. Reusch ◽

M. W. Stewart ◽

C. M. Perkins ◽

D. T. Cirkel ◽

J. Ye ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Receptor Agonist ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Increased Prevalence of Upper Gastrointestinal Symptoms in Long-term Type 1 Diabetes Mellitus

Diabetic Medicine ◽

10.1002/(sici)1096-9136(199605)13:5<478::aid-dia104>3.0.co;2-5 ◽

1996 ◽

Vol 13 (5) ◽

pp. 478-481 ◽

Cited By ~ 71

Author(s):

E. Schvarcz ◽

M. Palmér ◽

C.M. Ingberg ◽

J. Åman ◽

C. Berne

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Type 1 Diabetes Mellitus ◽

Upper Gastrointestinal ◽

Term Type

Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial

Alimentary Pharmacology & Therapeutics ◽

10.1046/j.1365-2036.2000.00868.x ◽

2000 ◽

Vol 14 (12) ◽

pp. 1653-1661 ◽

Cited By ~ 167

Author(s):

N. J. Talley ◽

M. Verlinden ◽

W. Snape ◽

J. A. Beker ◽

P. Ducrotte ◽

...

Keyword(s):

Gastric Emptying ◽

Functional Dyspepsia ◽

Receptor Agonist ◽

Delayed Gastric Emptying ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Motilin Receptor

Faculty Opinions recommendation of A small particle size diet reduces upper gastrointestinal symptoms in patients with diabetic gastroparesis: a randomized controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718234590.793489907 ◽

2014 ◽

Author(s):

Klaus Bielefeldt

Keyword(s):

Particle Size ◽

Randomized Controlled Trial ◽

Small Particle ◽

Controlled Trial ◽

Diabetic Gastroparesis ◽

Small Particle Size ◽

Randomized Controlled ◽

Using ginger supplement in adjunct with non-surgical periodontal therapy improves metabolic and periodontal parameters in patients with type 2 diabetes mellitus and chronic periodontitis: A double-blind, placebo-controlled trial

Journal of Herbal Medicine ◽

10.1016/j.hermed.2019.100315 ◽

2020 ◽

Vol 20 ◽

pp. 100315

Author(s):

Hasan Gholinezhad ◽

Hadi Bazyar ◽

Homeira Rashidi ◽

Parvin Salehi ◽

Mohammad Hosein Haghighi-zadeh ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Chronic Periodontitis ◽

Controlled Trial ◽

Periodontal Therapy ◽

Double Blind ◽

Double Blind Placebo

Effect of Difelikefalin, a Selective Kappa Opioid Receptor Agonist, on Respiratory Depression: A Randomized, Double‐Blind, Placebo‐Controlled Trial

Clinical and Translational Science ◽

10.1111/cts.13042 ◽

2021 ◽

Author(s):

Eugene R. Viscusi ◽

Marc C. Torjman ◽

Catherine L. Munera ◽

Joseph W. Stauffer ◽

Beatrice S. Setnik ◽

...

Keyword(s):

Respiratory Depression ◽

Opioid Receptor ◽

Receptor Agonist ◽

Controlled Trial ◽

Kappa Opioid Receptor ◽

Kappa Opioid ◽

Double Blind ◽

Double Blind Placebo ◽

Opioid Receptor Agonist

Efficacy and Tolerability of Linagliptin Added to a Sulfonylurea Regimen in Patients With Inadequately Controlled Type 2 Diabetes Mellitus: An 18-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2012.07.008 ◽

2012 ◽

Vol 34 (9) ◽

pp. 1909-1919.e15 ◽

Cited By ~ 37

Author(s):

Andrew J. Lewin ◽

Lisa Arvay ◽

Dacheng Liu ◽

Sanjay Patel ◽

Maximilian von Eynatten ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo